Notices

Connecting Science with Innovation

Welcome to this dedicated space designed for you to discover the different peptide models and the scientific research currently revolutionizing the market. Our goal is to share clear, updated, and evidence-based information with you regarding the mechanisms of action and regulatory advancements of these amino acid chains. We invite you to explore the future of biotechnology applied to performance and regeneration.

Peptide-Based Targeted Therapies for Breast Cancer

Peptides have become key tools in precision oncology: specific, low in immunogenicity, and modularly designed. This infographic summarizes the four platforms redefining the field: peptide vaccines, engineered exosomes, functionalized nanoparticles, and peptide-drug conjugates (PDCs).

They do not compete—they complement each other. Each fits a distinct need based on subtype, target receptor, and clinical context, paving the way for more personalized and combined therapies.

Full review at the link:

https://www.sciencedirect.com/science/article/pii/S0753332226007432

Tesamorelin: Mechanism of Action and Metabolic Benefits

Tesamorelin is a GHRH analog that binds to receptors in the anterior pituitary gland and stimulates the pulsatile release of endogenous growth hormone (GH), promoting lipolysis and reducing visceral and hepatic fat. In a clinical trial conducted in individuals with HIV and NAFLD (MASLD), it reduced hepatic fat content, attenuated the progression of fibrosis, and improved systemic inflammation (C-reactive protein).

Clinical evidence in an HIV and NAFLD population.

Full study at the link:

https://www.sciencedirect.com/science/article/abs/pii/S2352301819303388

Tesamorelin: Mechanism of Action and Metabolic Benefits

Tesamorelin is a GHRH analog that binds to receptors in the anterior pituitary gland and stimulates the pulsatile release of endogenous growth hormone (GH), promoting lipolysis and reducing visceral and hepatic fat. In a clinical trial conducted in individuals with HIV and NAFLD, it reduced hepatic fat content, attenuated the progression of fibrosis, and improved systemic inflammation (C-reactive protein).

Clinical evidence in an HIV and NAFLD population. Full study at the link:

https://www.sciencedirect.com/science/article/abs/pii/S2352301819303388

🚨 FDA Announces Major Changes in Peptide Regulation

Several peptides that were previously restricted are officially being reclassified, marking a new era for research and the biotechnology sector. Stay informed on the latest updates and discover what this regulatory transition means.

🔗 Learn more here

https://www.biopharmadive.com/news/fda-peptides-rfk-advisory-committee-restrictions/817685/

https://www.forbes.com/health/weight-loss/fda-ease-peptide-restrictions-lmandp5/

PT-141 (Bremelanotide): A Different Approach to Understanding Sexual Response

Unlike PDE-5 inhibitors, which act primarily on vascular circulation, PT-141 exerts its mechanism of action directly within the central nervous system by activating melanocortin receptors (MC4R) involved in sexual desire and response pathways.

This infographic summarizes key differences between both mechanisms and highlights how they represent complementary approaches from a scientific perspective.

Learn more about its mechanism of action, available evidence, and research applications at the following link:

https://www.sciencedirect.com/science/article/abs/pii/S0090429504012725

Tirzepatide: Dual Action for Comprehensive Metabolic Support

Tirzepatide is a next-generation peptide that dual-targets GIP and GLP-1 receptors, helping to comprehensively regulate metabolic function. According to scientific research, it can improve glycemic control in individuals with type 2 diabetes, support significant weight loss, reduce cardiovascular risk factors, enhance liver health by decreasing hepatic fat accumulation, and contribute to lower metabolic inflammation. While these findings are highly promising, its application should always form part of an individualized treatment protocol under medical supervision.

Review the scientific evidence here:

https://pdf.sciencedirectassets.com/271044/1-s2.0-S0196978125X00048/1-s2.0-S0196978125000415/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEG0aCXVzLWVhc3QtMSJIMEYCIQDE4Oh5P5j%2FoiGJSDMJzHSentktM8Yr5jNVyCFtdlvbFQIhANcqc49VyFILCLVRbbnCE%2FMwiyMg8K66lt1I2fTwOrtwKrMFCDYQBRoMMDU5MDAzNTQ2ODY1IgzHE0cG9sHZDyylF4MqkAV3Hq18srj9RV0hGRO8UDiLBZjw3ZCQ34P%2FDs7FAF%2FIibMiKe07gHOB7syST9

Tesamorelin: Science and Metabolic Research

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog engineered to stimulate the physiological secretion of endogenous growth hormone. Scientific evidence has demonstrated its ability to reduce visceral adipose tissue, improve body composition, and support liver health in targeted populations—making it one of the most thoroughly researched peptide therapies in modern metabolic science.

At PrimeHack Peptides, we are committed to evidence-based education and delivering clear, responsible insights into peptide technology.

Explore the scientific research behind Tesamorelin here:

https://www.sciencedirect.com/science/article/abs/pii/S1096637414001208